Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.

Wang SH, Smith D, Cao Z, Chen J, Acosta H, Chichester JA, Yusibov V, Streatfield SJ, Fattom A, Baker JR Jr.

Vaccine. 2019 Mar 14;37(12):1591-1600. doi: 10.1016/j.vaccine.2019.02.002. Epub 2019 Feb 19.

PMID:
30795941
2.

A novel nanoemulsion vaccine induces mucosal Interleukin-17 responses and confers protection upon Mycobacterium tuberculosis challenge in mice.

Ahmed M, Smith DM, Hamouda T, Rangel-Moreno J, Fattom A, Khader SA.

Vaccine. 2017 Sep 5;35(37):4983-4989. doi: 10.1016/j.vaccine.2017.07.073. Epub 2017 Jul 31.

3.

Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults.

Landrum ML, Lalani T, Niknian M, Maguire JD, Hospenthal DR, Fattom A, Taylor K, Fraser J, Wilkins K, Ellis MW, Kessler PD, Fahim RE, Tribble DR.

Hum Vaccin Immunother. 2017 Apr 3;13(4):791-801. doi: 10.1080/21645515.2016.1248326. Epub 2016 Dec 23.

4.

Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats.

O'Konek JJ, Makidon PE, Landers JJ, Cao Z, Malinczak CA, Pannu J, Sun J, Bitko V, Ciotti S, Hamouda T, Wojcinski ZW, Lukacs NW, Fattom A, Baker JR Jr.

Hum Vaccin Immunother. 2015;11(12):2904-12. doi: 10.1080/21645515.2015.1075680.

5.

Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.

Fattom A, Matalon A, Buerkert J, Taylor K, Damaso S, Boutriau D.

Hum Vaccin Immunother. 2015;11(3):632-41. doi: 10.4161/hv.34414.

6.

Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model.

Passmore C, Makidon PE, O'Konek JJ, Zahn JA, Pannu J, Hamouda T, Bitko V, Myc A, Lukacs NW, Fattom A, Baker JR Jr.

Hum Vaccin Immunother. 2014;10(3):615-22. Epub 2013 Dec 10.

7.

Capsular serotype of Staphylococcus aureus in the era of community-acquired MRSA.

Sutter DE, Summers AM, Keys CE, Taylor KL, Frasch CE, Braun LE, Fattom AI, Bash MC.

FEMS Immunol Med Microbiol. 2011 Oct;63(1):16-24. doi: 10.1111/j.1574-695X.2011.00822.x. Epub 2011 Jul 18.

8.

An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children.

Huda T, Nair H, Theodoratou E, Zgaga L, Fattom A, El Arifeen S, Rubens C, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S27. doi: 10.1186/1471-2458-11-S3-S27. Review.

9.

Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.

Malin DH, Moon WD, Goyarzu P, Magallanes N, Blair MB, Alexander MR, McDavid L, Spurgeon JL, Ennifar S, Fattom A.

Nicotine Tob Res. 2010 Apr;12(4):438-44. doi: 10.1093/ntr/ntq021. Epub 2010 Mar 4.

PMID:
20203107
10.

Serotyping of Dutch Staphylococcus aureus strains from carriage and infection.

Melles DC, Taylor KL, Fattom AI, van Belkum A.

FEMS Immunol Med Microbiol. 2008 Mar;52(2):287-92. doi: 10.1111/j.1574-695X.2008.00376.x. Epub 2008 Jan 22.

11.

Distribution of capsular and surface polysaccharide serotypes of Staphylococcus aureus.

von Eiff C, Taylor KL, Mellmann A, Fattom AI, Friedrich AW, Peters G, Becker K.

Diagn Microbiol Infect Dis. 2007 Jul;58(3):297-302. Epub 2007 Mar 26.

PMID:
17376630
12.

Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests.

Verdier I, Durand G, Bes M, Taylor KL, Lina G, Vandenesch F, Fattom AI, Etienne J.

J Clin Microbiol. 2007 Mar;45(3):725-9. Epub 2007 Jan 3.

13.

A novel imidazole nucleoside containing a diaminodihydro-S-triazine as a substituent: inhibitory activity against the West Nile virus NTPase/helicase.

Ujjinamatada RK, Agasimundin YS, Zhang P, Hosmane RS, Schuessler R, Borowski P, Kalicharran K, Fattom A.

Nucleosides Nucleotides Nucleic Acids. 2005;24(10-12):1775-88.

PMID:
16438047
14.

Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins.

Sood RK, Fattom A.

Expert Opin Investig Drugs. 1998 Mar;7(3):333-47.

PMID:
15991976
15.

Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia.

Roghmann M, Taylor KL, Gupte A, Zhan M, Johnson JA, Cross A, Edelman R, Fattom AI.

J Hosp Infect. 2005 Jan;59(1):27-32.

PMID:
15571850
16.

Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients.

Fattom A, Fuller S, Propst M, Winston S, Muenz L, He D, Naso R, Horwith G.

Vaccine. 2004 Dec 16;23(5):656-63.

PMID:
15542186
17.

Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines.

Robbins JB, Schneerson R, Horwith G, Naso R, Fattom A.

Am Heart J. 2004 Apr;147(4):593-8.

PMID:
15077073
18.

Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials.

Fattom AI, Horwith G, Fuller S, Propst M, Naso R.

Vaccine. 2004 Feb 17;22(7):880-7. Review.

PMID:
15040941
19.

Meeting summary: possibilities for active and passive vaccination against opportunistic infections.

Walker RI, Blanchard T, Braun JM, Cebra JJ, Cross AS, Fattom A, Giannasca PJ, Holder IA, Huebner J, Matthews R, Pier GB, Romani L, von Specht BU, Trautmann M.

Vaccine. 2004 Feb 17;22(7):801-4. No abstract available.

PMID:
15040930
20.

Potent inhibition of NTPase/helicase of the West Nile Virus by ring-expanded ("fat") nucleoside analogues.

Zhang N, Chen HM, Koch V, Schmitz H, Minczuk M, Stepien P, Fattom AI, Naso RB, Kalicharran K, Borowski P, Hosmane RS.

J Med Chem. 2003 Oct 23;46(22):4776-89.

PMID:
14561097
21.

Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.

Zhang N, Chen HM, Koch V, Schmitz H, Liao CL, Bretner M, Bhadti VS, Fattom AI, Naso RB, Hosmane RS, Borowski P.

J Med Chem. 2003 Sep 11;46(19):4149-64.

PMID:
12954067
22.

in vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring system.

Zhang N, Chen HM, Sood R, Kalicharran K, Fattom AI, Naso RB, Barnard DL, Sidwell RW, Hosmane RS.

Bioorg Med Chem Lett. 2002 Dec 2;12(23):3391-4.

PMID:
12419368
23.

Passive immunization against nicotine attenuates nicotine discrimination.

Malin DH, Alvarado CL, Woodhouse KS, Karp H, Urdiales E, Lay D, Appleby P, Moon WD, Ennifar S, Basham L, Fattom A.

Life Sci. 2002 Apr 26;70(23):2793-8.

PMID:
12269383
24.

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R.

N Engl J Med. 2002 Feb 14;346(7):491-6.

25.

Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells.

Sood RK, Bhadti VS, Fattom AI, Naso RB, Korba BE, Kern ER, Chen HM, Hosmane RS.

Antiviral Res. 2002 Feb;53(2):159-64.

PMID:
11750942
26.

Inhibition of nicotine-induced seizures in rats by combining vaccination against nicotine with chronic nicotine infusion.

Tuncok Y, Hieda Y, Keyler DE, Brown S, Ennifar S, Fattom A, Pentel PR.

Exp Clin Psychopharmacol. 2001 May;9(2):228-34.

PMID:
11518099
27.

Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome.

Malin DH, Lake JR, Lin A, Saldaña M, Balch L, Irvin ML, Chandrasekara H, Alvarado CL, Hieda Y, Keyler DE, Pentel PR, Ennifar S, Basham LE, Naso R, Fattom A.

Pharmacol Biochem Behav. 2001 Jan;68(1):87-92.

PMID:
11274712
28.

Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(DL-lactide-co-glycolide) microspheres.

O'Brien CN, Guidry AJ, Fattom A, Shepherd S, Douglass LW, Westhoff DC.

J Dairy Sci. 2000 Aug;83(8):1758-66.

29.
30.

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats.

Pentel PR, Malin DH, Ennifar S, Hieda Y, Keyler DE, Lake JR, Milstein JR, Basham LE, Coy RT, Moon JW, Naso R, Fattom A.

Pharmacol Biochem Behav. 2000 Jan 1;65(1):191-8.

PMID:
10638653
31.

Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia.

Campbell W, Hendrix E, Schwalbe R, Fattom A, Edelman R.

Crit Care Med. 1999 Apr;27(4):798-801.

PMID:
10321672
32.
33.

Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis.

Guidry A, Fattom A, Patel A, O'Brien C, Shepherd S, Lohuis J.

Am J Vet Res. 1998 Dec;59(12):1537-9.

PMID:
9858402
34.

Antigenic determinants of Staphylococcus aureus type 5 and type 8 capsular polysaccharide vaccines.

Fattom AI, Sarwar J, Basham L, Ennifar S, Naso R.

Infect Immun. 1998 Oct;66(10):4588-92.

35.

Molecular, antibiogram and serological typing of Staphylococcus aureus isolates recovered from Al-Makased Hospital in East Jerusalem.

Essawi T, Na'was T, Hawwari A, Wadi S, Doudin A, Fattom AI.

Trop Med Int Health. 1998 Jul;3(7):576-83.

36.

Antibodies to group B streptococci in neonates and infants.

Berg S, Kasvi S, Trollfors B, Pilichowska-Paszkiet J, Fattom A, Tessin I, Lagergård T.

Eur J Pediatr. 1998 Mar;157(3):221-4.

PMID:
9537489
37.

Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients.

Na'was T, Hawwari A, Hendrix E, Hebden J, Edelman R, Martin M, Campbell W, Naso R, Schwalbe R, Fattom AI.

J Clin Microbiol. 1998 Feb;36(2):414-20.

38.

Prevalence of capsular serotypes among Staphylococcus aureus isolates from cows with mastitis in the United States.

Guidry A, Fattom A, Patel A, O'Brien C.

Vet Microbiol. 1997 Dec;59(1):53-8.

PMID:
9460196
39.
40.

Staphylococcus aureus vaccination for dialysis patients--an update.

Fattom AI, Naso R.

Adv Ren Replace Ther. 1996 Oct;3(4):302-8. Review.

PMID:
8914693
41.
42.

Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults.

Kotloff KL, Fattom A, Basham L, Hawwari A, Harkonen S, Edelman R.

Vaccine. 1996 Apr;14(5):446-50.

PMID:
8735558
43.

A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B streptococcus type-specific antibodies in humans.

Basham LE, Pavliak V, Li X, Hawwari A, Kotloff KL, Edelman R, Fattom A.

Vaccine. 1996 Apr;14(5):439-45.

PMID:
8735557
44.

Staphylococcal vaccines: a realistic dream.

Fattom AI, Naso R.

Ann Med. 1996 Feb;28(1):43-6. Review.

PMID:
8932505
45.

Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.

Welch PG, Fattom A, Moore J Jr, Schneerson R, Shiloach J, Bryla DA, Li X, Robbins JB.

J Am Soc Nephrol. 1996 Feb;7(2):247-53.

46.

Polysaccharide conjugate vaccines for the prevention of gram-positive bacterial infections.

Naso R, Fattom A.

Adv Exp Med Biol. 1996;397:133-40. Review. No abstract available.

PMID:
8718592
47.

Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides.

Fattom A, Li X, Cho YH, Burns A, Hawwari A, Shepherd SE, Coughlin R, Winston S, Naso R.

Vaccine. 1995 Oct;13(14):1288-93.

PMID:
8585282
48.

Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines.

Robbins JB, Schneerson R, Vann WF, Bryla DA, Fattom A.

Ann N Y Acad Sci. 1995 May 31;754:68-82. Review. No abstract available.

PMID:
7625682
49.
50.

Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines.

Coughlin RT, Fattom A, Chu C, White AC, Winston S.

Vaccine. 1995 Jan;13(1):17-21.

PMID:
7762272

Supplemental Content

Loading ...
Support Center